EN
登录

On-Device AI医疗保健公司Noul成为首家加入瑞士疟疾集团的韩国诊断公司

On-Device AI Healthcare Company Noul Becomes First Korean Diagnostic Company to Join Swiss Malaria Group

CISION 等信源发布 2024-02-12 16:00

可切换为仅中文


Join global network led by international organizations and global pharmaceutical companies

加入由国际组织和全球制药公司领导的全球网络

Obtain a membership in recognition of innovation in malaria diagnostic solution

获得疟疾诊断解决方案创新认可会员资格

Strengthen global leadership in malaria diagnosis based on European subsidiary

以欧洲子公司为基础,加强疟疾诊断领域的全球领导地位

YONGIN, South Korea, Feb. 12, 2024 /PRNewswire/ -- Noul Co., Ltd., (376930.KR), an On-Device AI healthcare company, announced that its European subsidiary (noul GmbH) has become an official member of the Swiss Malaria Group, a Swiss public, private, academic & civil society leadership network for a malaria-free world..

韩国YONGIN,2024年2月12日/PRNewswire/--Noul Co.,Ltd.(376930.KR),一家在线AI医疗保健公司,宣布其欧洲子公司(Noul GmbH)已成为瑞士疟疾组织的正式成员,瑞士疟疾组织是瑞士公共、私人、学术和民间社会领导网络,旨在实现无疟疾世界。。

Continue Reading

继续阅读

Noul and SMG Logo

新款和SMG标志

The recognition of innovation in the malaria diagnostic solution, miLab™ MAL played a major role in Noul becoming an official member of the Swiss Malaria Group. Through this membership, Noul will have a voice in the decision-making process towards developing healthcare policies to eradicate global malaria and will strengthen its global cooperation with other group members (Global Fund, FIND, MMV, Swiss TPH, Terre des Hommes, global pharmaceutical companies, and other civil society organizations) to consolidate its leadership in the field of malaria diagnosis..

由于对疟疾诊断解决方案创新的认可,miLab™MAL在Noul成为瑞士疟疾组织的正式成员中发挥了重要作用。通过这一成员身份,Noul将在制定根除全球疟疾的医疗保健政策的决策过程中拥有发言权,并将加强与其他集团成员(全球基金、FIND、MMV、瑞士TPH、地球社、全球制药公司和其他民间社会组织)的全球合作巩固其在疟疾诊断领域的领导地位。。

As Noul's malaria diagnostic solution, miLab™ MAL was introduced as 'an innovative product that will enter scale-up level' in Unitaid's 2022 Annual Report, it is getting attention from the international community as an innovative malaria diagnostic solution that overcomes the limitation of rapid diagnostic testing and manual microscopic diagnosis.

作为Noul的疟疾诊断解决方案,miLab™MAL在Unitaid的2022年年度报告中被介绍为“一种将进入放大水平的创新产品”,它作为一种创新的疟疾诊断解决方案,克服了快速诊断测试和手动显微镜诊断的局限性,受到了国际社会的关注。

According to the results of a clinical study of a total of 1,649 patients in Ethiopia and Ghana, unveiled in October 2023 at the American Academy of Tropical Medicine and Hygiene (ASTMH), miLab™ MAL showed significantly higher sensitivity and specificity in diagnosis of P. falciparum and P. vivax malaria compared to field microscopy test.

根据2023年10月在美国热带医学与卫生研究院(ASTMH)公布的对埃塞俄比亚和加纳1649名患者的临床研究结果,与野外显微镜检查相比,miLab™MAL在诊断恶性疟原虫和间日疟原虫方面显示出显着更高的敏感性和特异性。

It also showed high applicability in diagnosing parasites with the pfhrp2/3 deletions..

它在诊断pfhrp2/3缺失的寄生虫方面也显示出很高的适用性。。

Dr. Taehwan Kim, Managing Director of noul GmbH said, 'noul GmbH will play a pivotal role in global malaria diagnosis through its activities as a member of the Swiss Malaria Group. By utilizing Noul's innovative malaria diagnostic solution, we are going to further expand our presence in the market by leading strategies to eliminate global malaria and strengthening global cooperation with other group members.'Swiss Malaria Group said, 'Noul's innovative diagnostic tools align perfectly with the Swiss Malaria Group's emphasis on innovative solutions in the fight against malaria.

noul GmbH董事总经理Taehwan Kim博士说,“noul GmbH将通过其作为瑞士疟疾组织成员的活动在全球疟疾诊断中发挥关键作用。通过利用Noul创新的疟疾诊断解决方案,我们将通过领导消除全球疟疾的战略和加强与其他集团成员的全球合作,进一步扩大我们在市场上的存在。”瑞士疟疾组织表示,“Noul的创新诊断工具与瑞士疟疾组织对疟疾防治创新解决方案的重视完全一致。

Noul, which focuses on diagnostic solutions in blood and tissue diagnostics, has developed a cutting-edge digital microscopy-based malaria diagnostic tool, miLab™ MAL.'Noul Website: https://noul.kr/en/Swiss Malaria Group Website: https://www.swissmalariagroup.ch/en/#SwissMalariaGroup #SMG #Noul #malaria #miLab #AI #innovationPhoto - https://mma.prnewswire.com/media/2335030/Photo__Noul_and_SMG.jpg Logo - https://mma.prnewswire.com/media/1854227/Noul_logo1_Logo.jpg.

Noul专注于血液和组织诊断中的诊断解决方案,开发了一种基于数字显微镜的先进疟疾诊断工具miLab™MAL.'Noul网站:https://noul.kr/en/Swiss疟疾组织网站:https://www.swissmalariagroup.ch/en/#SwissMalariaGroup#SMG#Noul#疟疾#miLab#AI#创新照片-https://mma.prnewswire.com/media/2335030/Photo__Noul_and_SMG.jpg徽标-https://mma.prnewswire.com/media/1854227/Noul_logo1_Logo.jpg.